Drugplain

Hair-Regen Hair Growth Treatment Derma Roller Included 5 g/100mL

Male Liquid Minoxidil (6pk) Derma Roller Included · LIQUID · Yiwu Yizhou Trading Co., Ltd

No Recall History
Plain English

Minoxidil is a topical medication applied directly to the scalp to help stimulate hair growth and treat male pattern baldness. This over-the-counter liquid formulation works by widening blood vessels in the scalp to increase blood flow to hair follicles.

Key Facts

Brand Name
Hair-Regen Hair Growth Treatment Derma Roller Included
Generic Name
Male Liquid Minoxidil (6pk) Derma Roller Included
NDC Code (Product)
84232-021
Manufacturer
Yiwu Yizhou Trading Co., Ltd
Strength
5 g/100mL
Dosage Form
LIQUID
Route
TOPICAL
Marketing Status
Drug Class
Arteriolar Vasodilator [EPC]
Marketing Start
02/06/2026

Recall History

No Recall History

Frequently Asked Questions

What is Hair-Regen Hair Growth Treatment Derma Roller Included used for?

Minoxidil is a topical medication applied directly to the scalp to help stimulate hair growth and treat male pattern baldness. This over-the-counter liquid formulation works by widening blood vessels in the scalp to increase blood flow to hair follicles.

Is Hair-Regen Hair Growth Treatment Derma Roller Included a controlled substance?

Hair-Regen Hair Growth Treatment Derma Roller Included is not classified as a controlled substance by the DEA.

What is the generic name for Hair-Regen Hair Growth Treatment Derma Roller Included?

The generic name for Hair-Regen Hair Growth Treatment Derma Roller Included is Male Liquid Minoxidil (6pk) Derma Roller Included. There are no other listed brand versions of Male Liquid Minoxidil (6pk) Derma Roller Included.

What is the NDC code for Hair-Regen Hair Growth Treatment Derma Roller Included 5 g/100mL?

The NDC (National Drug Code) for Hair-Regen Hair Growth Treatment Derma Roller Included 5 g/100mL is 84232-021, listed by Yiwu Yizhou Trading Co., Ltd.

Product NDC

84232-021

Package NDC

84232-021-26

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)